Catch up on the latest imaging research presented at the recent American Society for Radiation Oncology (ASTRO) Annual Meeting.
|Articles|March 7, 2004
Agfa plans new miniPACS for private practices
A new miniPACS for the private-practice, nonhospital environment is under development by Agfa and could be introduced before the end of the year, a company representative said at the ECR on Sunday. The system is designed as a scalable, entry-level
Advertisement
A new miniPACS for the private-practice, nonhospital environment is under development by Agfa and could be introduced before the end of the year, a company representative said at the ECR on Sunday.
The system is designed as a scalable, entry-level solution. Price was not disclosed, but it is likely to be well below the price of Agfa's hospital PACS. Initial markets will probably be Eastern Europe, France, Germany, and Italy, but others are possible as well, said Marcus Ostlander, Agfa's manager of healthcare informatics for Europe.
The new mini-system is designed to accommodate imaging volumes of up to 20,000 per year and would open a new market segment for Agfa. The company already has a range of PACS offerings for hospitals.
The basic system provides soft-copy reading for radiography, but options would extend it to MR and CT. Storage will be via DVD or CD-ROM. It includes an entry-level radiology information system that will allow a receptionist to collect demographic data to accompany the imaging study.
The system is being tested in several facilities, Ostlander said.
Advertisement
Related to this article
Tightness of the high-convexity sulci (THC) on brain MRI was associated with nearly threefold higher odds of cognitive decline over five to seven years of follow-up, according to a new prospective study involving over 2,100 community-dwelling senior citizens.
An AI model for prostate MRI offered an 89 percent AUC for prostate cancer detection in external validation testing, according to a newly published international multicenter study.
In the latest episode of her Breast Imaging in Focus series, Manisha Bahl, MD, MPH, FSBI, discusses new research comparing mammography-based AI models for breast cancer detection and short-term risk prediction.
In a recent episode of our Molecular Imaging in Focus series, Jack Andrews, MD, discussed pertinent findings from a recent intra-patient comparative study of PSMA PET agents in men with recurrent prostate cancer presented at the recent ASTRO conference.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Expert Radiology is a **radiologist-run teleradiology practice with 10 years of experience**, hiring teleradiologists earning **$500–$900/hr with per-dictation pay**. Work from anywhere with true flexibility, **no shifts, no call, and no weekends**.
Our case mix is **predominantly outpatient and noncontrast**, with approximately **75% MRI**, plus X-ray and CT.
We cover **malpractice with tail**, handle all medical licensing, and ship you a **$10K reading station with six vertical 4K monitors**.
Minimum commitment is an **average of 400 cases per month**.
**Book a call with Brandi Escapule, Principal, Physician Services.**
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
What a Large Prostate MRI Study Reveals About AI and Unassisted Radiologist Assessment
2
MRI Study Links Tightness of High-Convexity Sulci to Higher Risk of Cognitive Decline in Older Adults
3
Breast Imaging in Focus: Can AI Models for Breast Cancer Detection and Risk Prediction Be Used Interchangeably?
4
Research Highlights from the ASTRO 2026 Annual Meeting
5